Metformin displayed a lowest risk for dementia across diverse antidiabetics, while α-glucosidase inhibitors had the highest risk.
Modifiable risk factors tied to young-onset dementia
Dec 28, 2023
Some of the factors include social isolation, diabetes, heart disease, vitamin D deficiency, high C-reactive protein and low handgrip strength.
Catheter ablation for atrial fibrillation cuts risk for dementia, death
Aug 25, 2023
The findings persisted across age, sex and comorbidities.
Pioglitazone use linked to reduced dementia risk in T2DM
Feb 16, 2023
The reduction in risk was greatest for those with a history of ischemic heart disease or stroke.
US life expectancy drops for second year thanks to COVID-19, drug overdoses: CDC
By
Kimberly Bonvissuto
Jan 03, 2023
Life expectancy in the United States fell for a second consecutive year due to COVID-19 deaths and drug overdoses, falling to the shortest lifespan since 1996, according to a recent report from the Centers...
Thiazolidinedione monotherapy for T2DM tied to lower dementia risk
Oct 12, 2022
Sulfonylurea monotherapy was linked to increased risk for all-cause dementia compared with metformin monotherapy.